WHC is still in active development. Read this to understand our approach.
depiction of CMWTZPSULFXXJA-UHFFFAOYSA-N.svg
tripsit

naproxen

Check on tripsit

pubchem

Naproxen

Check on pubchem

drugmap

Naproxen

Check on drugmap

Data

InChI: InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)

Synonyms: Apronax,RS-3540,SR-01000003110-5,Ec-Naprosyn, (S)-Naproxen,2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)-,M1021,IDI1_000242,BRD-K59197931-001-02-9,NCGC00016759-02,(S)-(+)-Naproxen,NCGC00021127-01,SR-01000003110,Mnpa,Napratec,Naxyn 250,KBioSS_001457,Aleve,Danaprox,Prestwick_349,NAPROXEN [MART.],SCHEMBL3046, Ec-Naprosyn,Naproxeno [INN-Spanish],Genoxen,2-(6-Methoxy-2-naphthyl)propanoic acid , (+)-,Artrixen,Equiproxen, Leniartil,(S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid,GTPL5230,Anexopen,SPECTRUM1500425,Rahsen, 22204-53-1,Acusprain,CAS-22204-53-1, Naprosyne,NAPROXEN,Naxyn, Daprox,Proxen,(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid, Reuxen,(+)-2-(Methoxy-2-naphthyl)-propionsaeure [German],Spectrum5_001327,(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid,(+)-2-(Methoxy-2-naphthyl)-propionsaeure,Prestwick1_000791,VIMOVO COMPONENT NAPROXEN,(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,NAPROXEN [MI],Pronaxen,04N531,Xenar,(+)-2-(6-Methoxy-2-naphthyl)propionic acid,Headlon,NAPROXEN [INCI],Naproxen,(S),NAPROXEN [HSDB],UPCMLD-DP001,HMS2091H12,(2S)-2-(6-Methoxynaphth-2-yl)propanoic acid,Nalyxan,(+)-6-Methoxy-.alpha.-methyl-2-napthaleneacetic acid,Vinsen,Naprosyn,NSC750183,BRD-K59197931-236-09-6,Fuxen, Naproxeno,Bipronyl,(S)-2-(6-Methoxy-2-naphthyl)propionic acid,DB00788,Naprontag, Naixan,AKOS005267223,CG 3117,2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)-,SR-01000075977-3,Atiflan,BDBM50339185,KBioGR_000597,EN300-139795,Leniartil,Dysmenalgit,Napxen,2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)-,NAPROXEN [ORANGE BOOK],Saritilron,4po0,Naproxen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,d-2-(6-Methoxy-2-naphthyl)propionic acid,Naproxen [USAN:USP:INN:BAN:JAN],Anaprox,Dysmenalgit N,Tox21_301953,Nafasol, Naposin,Noflam,Naproxene [INN-French],NSC 750183,(alphas)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid,Spectrum4_000069,Proxen LLE,NAPROXEN [EP MONOGRAPH],57Y76R9ATQ, (S)-(+)-Naproxen,Naprosine,NAPROXEN [JAN],(+)-(S)-6-METHOXY-.ALPHA.-METHYL-2-NAPHTHALENEACETIC ACID,CCG-40130,HMS3886C15,Naxen,Sutolin,22204-53-1,(+)NAPROXEN,(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid,naproxen(+),Congex, Naprosyn,Xenar-CR,SPBio_002861,Naproxen, meets USP testing specifications, Artroxen,Tohexen, Novonaprox,Naproxen, British Pharmacopoeia (BP) Reference Standard,NSC 757239,Napmel,NAPROXEN [USAN],Prexan,(+)(S)2-(6-methoxy-2-naphthyl)-propionic acid,SR-01000075977,Daprox,Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material,ACT02593, Bonyl,Artroxen,DSSTox_CID_20686,NCGC00016759-03,Soproxen,(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid,2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (+)-,Prafena, Napren,EINECS 244-838-7,d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German],Spectrum3_000514, Atiflan,AB00052049-04,Naposin,Sinartrin,O10203,HSDB 3369, Danaprox,(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid,EC 244-838-7,HMS1920P13,NSC-750183,Proxine,Naprosyn (TN), Naprius,4or0,SDCCGSBI-0050769.P005,NCGC00016759-38,Flexen,Sutony,(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid,Sinton,Reuxen,Veradol,Naproxi 250,HMS2089N21,KBio2_004025,Naprolag, Congex,Napren E,Prestwick0_000791,NAPROXEN [WHO-DD],(S)-(+)-Naproxene,d-Naproxen; (2S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid; (S)-6-Methoxy-?-methyl-2-naphthaleneacetic Acid; d-2-(6-Methoxy-2-naphthyl)propionic Acid,(S)-2-(6-Methoxy-2-naphthyl)propanoic acid,AC-1363,BRD-K59197931-001-03-7,KBio2_001457, Axer,C01517,Naproxi 500,S5177,Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)-,Roxen,2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen),NAPROXEN [USP-RS],HY-15030,DL Naproxen,26159-31-9,Naproxen (JP17/USP/INN),Nycopren, Clinosyn,Naprux,Naxyn 500,Naprosyn LLE,2-(6-methoxynaphthalen-2-yl)propanoic acid,Flexipen,Naproxen 1.0 mg/ml in Methanol,Naproxenum, (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid,Naixan,(S)-2-(6-methoxynaphthalen-2-yl)propanoicacid,RS 3540,Laraflex,Traumox, Acusprain,Equiproxen (Veterinary),HMS500M04,U-Ritis,(S)-(+)-6-Methoxy-alp.-methyl-2-naphthalene acetic acid,d-Naproxen,Diocodal,Naproxen, VETRANAL(TM), analytical standard,(+)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid,Priaxen,NAPROXEN COMPONENT OF VIMOVO, Equiproxen,2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)-,Clinosyn, Flexipen, (+)-(S)-Naproxen,PN400 COMPONENT NAPROXEN,Lefaine,MFCD00010500,(+)-(S)-Naproxen, (+)-Naproxen,Arthrisil,(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, 98%,Duk,(S)-(+)-2-(6-methoxy-naphthalen-2-yl)-propionic acid,Narocin,AB00052049_05,Naprius,(2S)-2-(6-methoxy(2-naphthyl))propanoic acid,Axer,Anax,BIDD:GT0062,Napflam,NSC757239, Artagen,SPBio_000966,NAPROXEN [USP MONOGRAPH],Bonyl,(2S)-2-(6-methoxy-2-naphthyl)propanoic acid,Velsay,Patxen,Naprium,Floginax,Rheumaflex,(S)-6-Methoxy-.alpha.-methyl-2-naphthalene acetic acid, Naproxenum,NAPROXEN [GREEN BOOK],Epitope ID:139974,NCGC00161591-01, Artrixen,NAPROXEN [VANDF],Naxopren,Calosen,Lopac0_000792,NPS, Anexopen, Genoxen,Q-201447, Lefaine, Apronax,(+)-Naproxen,(S)-Naproxen,Naproxen 100 microg/mL in Acetonitrile,Apo-Napro-NA,NSC-757239,CCRIS 5265,CMWTZPSULFXXJA-VIFPVBQESA-,Q1215575,Naproxene,DivK1c_000242,Z1695772815, (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,ME-0100,Novonaprox,Panoxen,(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic Acid;(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid,Naprosy,SR-01000075977-4, d-Naproxen,(S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid,UPCMLD-DP001:001,131991-52-1,SR-01000075977-10,NCGC00255562-01,Naxen F,NINDS_000242, Nycopren,D00118,CHEMBL154,Prestwick2_000791,Naproxenum [INN-Latin],Proxen LE,Spectrum2_001043,Artagen,Napren,d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure,Apo-Naproxen,Naproxen, United States Pharmacopeia (USP) Reference Standard,NCGC00016759-01,Flanax Forte,UNII-57Y76R9ATQ,KBio2_006593, Bipronyl,AM20060551,CHEBI:7476,DTXSID4040686,Spectrum_000977,KBio3_001567,DSSTox_GSID_40686,Pharmakon1600-01500425,Naproxeno,BSPBio_002067,(S)-2-(6-methoxy-2-naphthyl)-propionic acid,SBI-0050769.P004, Naproxene,Naprosyn LLE Forte, Arthrisil, Nalyxan,Naprosyne,(+)-2-(Methoxy-2-naphthyl)-propionic acid, Calosen,Naproxen2-(6-Methoxy-naphthalen-2-yl)-propionic acid,DSSTox_RID_79542, Napflam,Naproxen,ZINC105216,NAPROXEN [INN],Narma, Laraflex,Naproxen, European Pharmacopoeia (EP) Reference Standard,HMS3649M13,KBio1_000242,Naproxen solution 1.0 mg/ml in methanol


Estimated data

Solubility: -3.469 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 36.0% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.